The company strives in the development and production of organic floro, pyridine, indole derivatives, chiral reagents, and pharmaceutical intermediates. The main products are the intermediates of tofacitinib, Aprepitant,Eravacycline,Cinacalcet, Vilazodone,Dolutegravir, Netupitant and Osimertinib, 5-Cyanoindole, 4,4-dimethylcyclohexanone,and Acacetine. Our R&D center and production base are located in Panjin Fine Chemical Park, Liaoning. The plant is equipped with several 300L-3000L enamel reactors, rectification towers, centrifuges, drying boxes and other typical production equipment. which can meet the production process range from -20 ℃ to 220 ℃. And we serve the following reactions accordingly:
Hydrogenation(cyano reduction, ester reduction, double bond, debenzylation, nitro,dehalogenation, hydrogenation under acid condition (< 5atm))
High temperature reaction,from 180℃ to 200℃
Grignard reaction: bromonation, friedel-crafts reaction,rectification(1mmHg~150℃), chiral resolution
Catalytic oxidization
Chiral Reduction,hydrogenation
Ortho-directed metallization
Diazotion
The company has a complete quality management system and has been certified with ISO9001: 2015. The testing equipment in our lab like liquid chromatography (HPLC), gas chromatography (GC), Karl Fischer moisture titrator, melting point meter, etc., help to ensure the quality of incoming raw materials, in-process control, and FG delivery. Our aim is to use a strong technical force and a high degree of professionalism to provide customers with products and technical services with the best quality/price ratio.
more >
Year of Establishment:
2000
Total Assets(USD):
choose not to disclose
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights: